Profile data is unavailable for this security.
About the company
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
- Revenue in USD (TTM)1.39bn
- Net income in USD122.26m
- Incorporated1987
- Employees7.40k
- LocationMerit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
- Phone+1 (801) 253-1600
- Fax+1 (801) 253-1652
- Websitehttps://www.merit.com/
More ▼
Mergers & acquisitions
| Acquired company | MMSI:NSQ since announced | Transaction value |
|---|---|---|
| Biolife LLC | -4.71% | 120.00m |
| Cook Medical LLC-Lead Management Business | -6.18% | 210.00m |
| EndoGastric Solutions Inc | 8.76% | 105.00m |
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | 2.50bn | -1.12bn | 3.33bn | 12.30k | -- | 1.11 | -- | 1.33 | -6.53 | -6.53 | 14.49 | 17.70 | 0.4165 | 4.28 | 6.21 | 203,569.10 | -18.70 | -2.08 | -21.69 | -2.53 | 54.77 | 56.91 | -44.90 | -5.58 | 1.82 | 3.40 | 0.3174 | -- | -2.18 | 1.90 | -1,016.37 | -- | -15.36 | -- |
| Haemonetics Corp | 1.36bn | 167.68m | 3.55bn | 3.02k | 22.25 | 4.34 | 12.52 | 2.61 | 3.32 | 3.32 | 26.82 | 17.02 | 0.5857 | 1.76 | 6.65 | 450,156.80 | 7.22 | 5.41 | 8.90 | 6.55 | 55.87 | 53.20 | 12.32 | 9.18 | 0.9857 | 26.25 | 0.5987 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Inspire Medical Systems Inc | 840.11m | 66.51m | 3.91bn | 1.25k | 60.73 | 6.14 | 51.83 | 4.65 | 2.18 | 2.18 | 27.58 | 21.57 | 1.19 | 1.73 | 10.19 | 674,246.40 | 9.39 | -4.83 | 10.38 | -5.43 | 84.65 | 84.59 | 7.92 | -5.12 | 7.44 | -- | 0.00 | -- | 28.49 | 57.80 | 352.96 | -- | 70.20 | -- |
| Integer Holdings Corp | 1.75bn | 78.00m | 4.28bn | 11.00k | 57.64 | 2.66 | 22.27 | 2.45 | 2.13 | 2.10 | 49.33 | 46.05 | 0.5445 | 4.87 | 4.94 | 158,744.70 | 2.43 | 3.28 | 2.60 | 3.54 | 27.10 | 26.70 | 4.47 | 6.38 | 2.14 | 4.30 | 0.4396 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| TransMedics Group Inc | 488.23m | 48.95m | 4.45bn | 728.00 | 100.97 | 16.70 | 62.93 | 9.11 | 1.30 | 1.30 | 13.37 | 7.87 | 0.6254 | 4.31 | 4.36 | 670,641.50 | 6.27 | -5.73 | 6.73 | -6.28 | 59.47 | 62.37 | 10.03 | -11.86 | 8.32 | 21.39 | 0.657 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Irhythm Technologies Inc | 618.59m | -98.32m | 4.94bn | 2.00k | -- | 56.97 | -- | 7.98 | -3.14 | -3.14 | 19.74 | 2.72 | 0.6739 | 12.97 | 7.26 | 309,293.50 | -10.71 | -20.12 | -12.08 | -24.37 | 69.39 | 68.61 | -15.89 | -23.90 | 5.58 | -- | 0.8819 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Teleflex Inc | 3.01bn | 149.53m | 5.28bn | 14.10k | 37.63 | 1.30 | 12.41 | 1.75 | 3.18 | 3.17 | 64.50 | 91.67 | 0.4112 | 2.10 | 6.59 | 213,485.40 | 2.04 | 4.58 | 2.23 | 5.01 | 55.68 | 54.77 | 4.97 | 11.38 | 1.32 | 7.59 | 0.3178 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Merit Medical Systems Inc | 1.39bn | 122.26m | 5.53bn | 7.40k | 45.86 | 3.87 | 22.78 | 3.98 | 2.04 | 2.04 | 23.12 | 24.18 | 0.5792 | 2.34 | 7.30 | 187,615.80 | 5.10 | 3.49 | 5.54 | 3.93 | 47.80 | 45.37 | 8.81 | 5.65 | 3.26 | 24.20 | 0.3384 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| Lantheus Holdings Inc | 1.54bn | 254.32m | 5.64bn | 808.00 | 23.13 | 4.84 | 17.78 | 3.67 | 3.52 | 3.52 | 21.62 | 16.84 | 0.7908 | 7.96 | 4.48 | 1,901,855.00 | 13.09 | 9.87 | 14.95 | 11.33 | 64.04 | 60.44 | 16.55 | 12.86 | 5.46 | -- | 0.3275 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| Glaukos Corp | 404.52m | -123.68m | 5.80bn | 995.00 | -- | 7.53 | -- | 14.33 | -2.31 | -2.31 | 7.42 | 13.46 | 0.4259 | 1.79 | 6.85 | 406,555.80 | -13.02 | -11.24 | -14.06 | -12.04 | 75.75 | 73.54 | -30.57 | -36.68 | 5.62 | -- | 0.083 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Guardant Health Inc | 774.00m | -416.55m | 6.30bn | 2.00k | -- | -- | -- | 8.14 | -3.38 | -3.38 | 6.28 | -2.03 | 0.5077 | 4.27 | 7.74 | 387,191.60 | -27.33 | -24.20 | -32.00 | -26.83 | 61.34 | 63.23 | -53.82 | -91.24 | 3.76 | -38.58 | 1.29 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Bruker Corp | 3.45bn | 79.60m | 6.33bn | 11.40k | 79.59 | 3.49 | 22.65 | 1.84 | 0.5252 | 0.5252 | 22.83 | 11.99 | 0.6602 | 1.56 | 5.74 | 302,395.60 | 1.53 | 6.80 | 2.04 | 9.20 | 49.28 | 50.00 | 2.32 | 9.66 | 0.7164 | 13.77 | 0.5331 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Bio Rad Laboratories Inc | 2.54bn | -2.16bn | 6.67bn | 7.70k | -- | 1.01 | -- | 2.62 | -76.20 | -76.20 | 90.48 | 241.72 | 0.2296 | 1.50 | 5.84 | 330,010.40 | -19.55 | 3.00 | -20.45 | 3.15 | 53.68 | 55.37 | -85.17 | 14.51 | 4.43 | 0.1031 | 0.1525 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Stevanato Group SpA | 1.32bn | 147.05m | 6.72bn | 5.52k | 45.73 | 4.05 | 28.34 | 5.10 | 0.5389 | 0.5389 | 4.83 | 6.08 | 0.4958 | 2.94 | 2.72 | 238,716.60 | 5.53 | 8.02 | 7.00 | 10.94 | 28.71 | 31.01 | 11.16 | 13.24 | 1.26 | -- | 0.2174 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Repligen Corp | 650.43m | -22.98m | 6.94bn | 1.78k | -- | 3.50 | 99.20 | 10.67 | -0.4124 | -0.4124 | 11.57 | 35.34 | 0.2282 | 1.81 | 4.94 | 365,820.60 | -0.8061 | 3.28 | -0.8557 | 3.70 | 51.15 | 54.24 | -3.53 | 12.37 | 5.79 | -- | 0.2106 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
Data as of Jun 30 2025. Currency figures normalised to Merit Medical Systems Inc's reporting currency: US Dollar USD
47.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 8.18m | 13.90% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 6.43m | 10.93% |
| Conestoga Capital Advisors LLCas of 31 Mar 2025 | 2.27m | 3.85% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 2.19m | 3.73% |
| Fuller & Thaler Asset Management, Inc.as of 31 Mar 2025 | 1.77m | 3.00% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 1.47m | 2.50% |
| Macquarie Investment Management Business Trustas of 31 Mar 2025 | 1.45m | 2.47% |
| Geode Capital Management LLCas of 31 Mar 2025 | 1.40m | 2.38% |
| Invesco Advisers, Inc.as of 31 Mar 2025 | 1.30m | 2.20% |
| Maverick Capital Ltd.as of 31 Mar 2025 | 1.27m | 2.16% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
